Filter
1601
Text search:
national
drug
authority
Featured
132
524
Language
Document type
921
238
224
96
69
20
18
8
2
2
1
1
Countries
98
76
71
66
47
44
44
42
41
41
35
34
33
32
29
29
26
24
24
22
19
18
17
17
15
11
11
10
10
9
9
8
8
7
6
6
6
6
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
823
87
69
67
48
30
23
Toolboxes
130
119
106
101
61
39
35
31
27
26
26
26
24
23
23
20
19
16
10
9
9
8
8
7
2
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
First edition, November 1997 | Revised July 2002
A survey of prevention, testing and treatment policies and practices
Malawi Health Sector Strategic Plan 2011 - 2016
recommended
Moving towards equity and quality
It provides insight into WHO’s work that aims to improve the health of the people of the United Republic of Tanzania in collaboration with key stakeholders.
Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety and comparative cost-effectiveness. They are intended to be available in functioning health
...
